NDT Pharmaceuticals Inc
NDT Pharmaceuticals Inc., a biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury. The company is based in Vienna, Virginia.
Market Cap & Net Worth: NDT Pharmaceuticals Inc (NDTP)
NDT Pharmaceuticals Inc (PINK:NDTP) has a market capitalization of $11.22 Million ($11.22 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #48590 globally and #14923 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NDT Pharmaceuticals Inc's stock price $0.07 by its total outstanding shares 160004349 (160.00 Million).
NDT Pharmaceuticals Inc Market Cap History: 2020 to 2025
NDT Pharmaceuticals Inc's market capitalization history from 2020 to 2025. Data shows change from $576.02 Million to $11.22 Million (-59.55% CAGR).
NDT Pharmaceuticals Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NDT Pharmaceuticals Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of NDTP by Market Capitalization
Companies near NDT Pharmaceuticals Inc in the global market cap rankings as of March 19, 2026.
Key companies related to NDT Pharmaceuticals Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
NDT Pharmaceuticals Inc Historical Marketcap From 2020 to 2025
Between 2020 and today, NDT Pharmaceuticals Inc's market cap moved from $576.02 Million to $ 11.22 Million, with a yearly change of -59.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $11.22 Million | +32.26% |
| 2024 | $8.48 Million | -13.54% |
| 2023 | $9.81 Million | +240.56% |
| 2022 | $2.88 Million | -98.35% |
| 2021 | $174.40 Million | -69.72% |
| 2020 | $576.02 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of NDT Pharmaceuticals Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.22 Million USD |
| MoneyControl | $11.22 Million USD |
| MarketWatch | $11.22 Million USD |
| marketcap.company | $11.22 Million USD |
| Reuters | $11.22 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.